Health
WHOOP is First Wearable to be Used in Phase 3 COVID-19 Vaccine Trials – PRNewswire
/PRNewswire/ — Abu Dhabi-based G42 Healthcare has announced a volunteer healthcare management program with Boston-based wearable technology firm WHOOP. The…
ABU DHABI, UAE, Aug. 13, 2020 /PRNewswire/ — Abu Dhabi-based G42 Healthcare has announced a volunteer healthcare management program with Boston-based wearable technology firm WHOOP. The partnership will offer volunteers participating in the world’s first Phase III trials of an inactivated COVID-19 vaccine the opportunity to benefit from a 24/7 fitness and health monitor to measure key biometrics. This is the first trial of its kind to feature wearable technology and will include thousands of vo…
-
Business11 hours ago1 ASX dividend stock down 43% I’d buy right now
-
General21 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts
-
Noosa News11 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Business15 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?